Skip to main content

Table 1 Characteristics of HIV-infected and HIV-uninfected women at enrollment into the study

From: A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women

Characteristic Hiv-infected (N = 115) Hiv-uninfected (N = 105) P-value
Median age (range, IQR) 37 (21–48, 33–41) 33 (21–46, 29–38) 0.0083
Married (n, %) 41 (35.7) 71 (67.3) <.0014
More than secondary school education (n, %) 10 (8.7) 16 (15.2) 0.1324
Home ownership (n, %) 19 (16.5) 28 (26.6) 0.0674
Walking distance to health care ≥60 min (n, %) 12 (11.4) 16 (13.6) 0.6874
Having medical conditions in the past 12 months1 (n, %) 104 (90.4) 101(96.2) 0.0914
Median number of lifetime sex partners (range, IQR) 4 (1–260) (3–8) 3 (1–10) (1–4) <.0015
Median age of first sex (range, IQR) 17.1 (12–26, 15–19) 18.1 (8–30, 16–20) 0.0253
Condom use > 75% of all coital events (n, %) 65 (56.5) 13 (12.5) <.0014
Median years of accumulative birth control use2 (range, IQR) 4 (0.1–20.3, 2–8) 4 (0.1–19, 2–7) 0.4833
Median number of pregnancy (range, IQR) 3 (1–9, 2–4) 3 (0–9, 2–4) 0.6333
Life history of cervical cancer screening (n, %) 68 (59.1) 32 (30.5) <.0014
Life history of tobacco use (n, %) 6 (5.3) 1 (1.0) 0.1216
Life history of Chlamydia trachomatis or Neisseria gonorrhea (n, %) 10 (8.7) 6 (5.8) 0.3954
  1. 1Tuberculosis, malaria, hypertension, diabetes, pneumonia, typhoid, or stomach pain/ulcer
  2. 2Intrauterine device, injectable contraceptive, or oral contraceptive pills
  3. 3P-value from t-test
  4. 4P-value from Chi-square test
  5. 5P-value from Wilcoxon rank sum test
  6. 6P-value from Fisher’s exact test